0001493152-20-012960.txt : 20200709
0001493152-20-012960.hdr.sgml : 20200709
20200709161413
ACCESSION NUMBER: 0001493152-20-012960
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200709
FILED AS OF DATE: 20200709
DATE AS OF CHANGE: 20200709
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lindstrom Richard
CENTRAL INDEX KEY: 0001310585
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-51030
FILM NUMBER: 201020624
MAIL ADDRESS:
STREET 1: 2811 WESTWOOD ROAD
CITY: WAYZATA
STATE: MN
ZIP: 55391
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: TearLab Corp
CENTRAL INDEX KEY: 0001299139
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 593434771
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9980 HUENNEKENS ST.
STREET 2: SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: 858-794-1400
MAIL ADDRESS:
STREET 1: 9980 HUENNEKENS ST.
STREET 2: SUITE 100
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: OccuLogix, Inc.
DATE OF NAME CHANGE: 20040730
4
1
ownership.xml
X0306
4
2020-07-09
1
0001299139
TearLab Corp
TEAR
0001310585
Lindstrom Richard
150 LA TERRAZA BLVD., STE 101
ESCONDIDO,
CA
92025
1
0
0
0
Common Stock
2020-07-09
4
U
0
14778
0.0586
D
0
D
Common Stock
2020-07-09
4
U
0
6000
0.0586
D
0
I
See footnote
Warrant (right to purchase)
11.25
2020-07-09
4
U
0
6666
243.29
D
2021-05-09
Common Stock
6666
0
D
Pursuant to the terms of the Agreement and Plan of Merger, dated May 11, 2020 (the "Merger Agreement"), among Accelmed Partners II LP, a Cayman Islands exempted limited partnership ("Buyer"), the Issuer and Accelmed Merger Sub, Inc., a Delaware corporation and a wholly owned subsidiary of Buyer, each issued and outstanding share of Issuer common stock and preferred stock (other than Cancelled Shares (as defined in the Merger Agreement)) was cancelled and automatically converted into the right to receive an amount equal to $0.0586 per share in cash, without interest and less any required withholding taxes, effective at the time of the Merger (as defined in the Merger Agreement).
Shares held by Lindstrom Family #2 Limited Partnership.
The warrant will be exercisable from the later of (i) stockholder approval to increase the authorized number of shares of common stock of the Issuer, and (ii) 12 months from the date of issuance and will expire five years from the date on which such warrant becomes exercisable.
Pursuant to the terms of the Warrant Termination Agreement by and between the Reporting Person and the Issuer, effective July 2, 2020, immediately prior to the consummation of Merger, the warrant automatically terminated and the Reporting Person is entitled to receive a total payment of $243.29 in exchange for such cancellation, to be paid within five (5) days following the consummation of the Merger.
/s/ Michael Marquez, as Attorney-in-Fact
2020-07-09